These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 13570730

  • 1. Second field evaluation of bivalent Types 4 and 7 adenovirus vaccine.
    HILLEMAN MR, GREENBERG JH, WARFIELD MS, ANDERSON SA, GLABERE RR.
    AMA Arch Intern Med; 1958 Sep; 102(3):428-36. PubMed ID: 13570730
    [No Abstract] [Full Text] [Related]

  • 2. Adenovirus vaccine; development, field evaluation, and appraisal of the need for vaccination in military and civilian populations.
    HILLEMAN MR.
    AMA Arch Intern Med; 1958 Jan; 101(1):47-53. PubMed ID: 13486965
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TESTING THE EFFECTIVENESS OF LIVE ADENOVIRUS VACCINE. II. IMMUNOGENIC PROPERTIES.
    SELIVANOV AA, PLESHANOVA RA, SMORODINTSEV AA.
    Acta Virol; 1964 May; 8():271-6. PubMed ID: 14173475
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Results of immunization of volunteers with live attenuated adenovirus vaccine type IV, V and VII. (Preliminary communication)].
    SMORODINTSEV AA, SELIVANOV AA.
    Vopr Virusol; 1959 May; 4():648-52. PubMed ID: 13832219
    [No Abstract] [Full Text] [Related]

  • 11. Safety evaluation of adenovirus type 4 and type 7 vaccine live, oral in military recruits.
    Choudhry A, Mathena J, Albano JD, Yacovone M, Collins L.
    Vaccine; 2016 Aug 31; 34(38):4558-4564. PubMed ID: 27475474
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. ADENOVIRUS VACCINE STUDIES. MR 005.09-1203.1.
    ROSENBAUM MJ, MILLER LF, EDWARDS EA, PIERCE WE.
    Rep U S Nav Med Res Lab; 1964 Aug 31; 10():1-18. PubMed ID: 24547284
    [No Abstract] [Full Text] [Related]

  • 16. Efficacy of and indications for use of adenovirus vaccine.
    HILLEMAN MR.
    Am J Public Health Nations Health; 1958 Feb 31; 48(2):153-8. PubMed ID: 13521062
    [No Abstract] [Full Text] [Related]

  • 17. Live and killed adenovirus vaccines for the prevention of acute respiratory disease in recruits.
    Pierce WE, Peckinpaugh RO, Frazier WE, Griffin JP, Greenberg BH, Jackson GG.
    Antimicrob Agents Chemother (Bethesda); 1965 Feb 31; 5():55-8. PubMed ID: 4286921
    [No Abstract] [Full Text] [Related]

  • 18. Combinations of Asian influenza virus and adenovirus vaccine in the prophylaxis of respiratory illness of Navy recruits. (Part I).
    SCHULTZ I, STILLE WT, GUNDELFINGER BF, MILLER LF.
    Am J Public Health Nations Health; 1960 Apr 31; 50(4):543-50. PubMed ID: 14443778
    [No Abstract] [Full Text] [Related]

  • 19. Immunization with live types 7 and 4 adenovirus vaccines. I. Safety, infectivity, antigenicity, and potency of adenovirus type 7 vaccine in humans.
    Top FH, Grossman RA, Bartelloni PJ, Segal HE, Dudding BA, Russell PK, Buescher EL.
    J Infect Dis; 1971 Aug 31; 124(2):148-54. PubMed ID: 4330997
    [No Abstract] [Full Text] [Related]

  • 20. Protection and infection rates in influenza and adenovirus vaccine evaluations.
    STILLE WT.
    Am J Hyg; 1960 Mar 31; 71():129-33. PubMed ID: 13834680
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.